BioSpace News Archive

Bureau Veritas announced the appointment of Alan Sikarskie as Vice President and Chief Operating Officer, effective immediately.

Agencies Can Reach Urban Audiences with PSAs on NRS’ 8,000+ Consumer-Facing Digital Out-Of-Home Screens at Independent Retailers Nationwide

Eli Lilly and Company will participate in the Barclays Global Healthcare Conference on Tuesday, March 10, 2020.

Meritech partners with DevelopmentalFX to help transform the lives of children and families affected by neurodevelopmental disorders so that they can live to their fullest potential.

Senzer has secured the Investigational New Drug application and data package for its ongoing FDA registration programme from its former US strategic partner and will now push ahead to get its cannabinoid respiratory device approved for treating side effects induced by anti-cancer treatments in the world’s largest pharmaceutical market.

Feel, the innovative mental health program, is offered to Gothaer Life Insurance customers

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and production of their biologics, vaccines and gene therapies, announced today that Steve Bagshaw, chief executive officer of FDB, has decided to retire from his current position, effective April 1, 2020.

- The following quote is attributed to Susan Mayne , Ph.D., director of the Center for Food Safety and Applied Nutrition “The FDA is committed to keeping consumers safe from potentially contaminated cosmetic products. As part of this effort, in September 2018 , the agency awarded AMA Analytical Services, Inc. (AMA) a on

Latest enhancements will help prevent interruption of medication availability

Evolution Research Group, a leading independent clinical research site company with a focus in neuroscience and other special populations, has acquired Staten Island, NY-based Richmond Behavioral Associates.